Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 24 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
16 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
PHARMACIE LEJEUNE from Faimes, company number BE0432865270, closed financial year 2025 with a result of € -169,264 after tax. For that financial year PHARMACIE LEJEUNE recorded revenue of € 12.4 million and equity of € 13.2 million. Compared with financial year 2024, the result moved from € 930,814 to € -169,264. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 17, 2026.
€ 13.2 million
▲ 16% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -169,264
▼ still € 930,814 profit in 2024
Profit after tax over the fiscal year.
€ 1.3 million
▲ 93% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 5.9 million.
People and assets in 2025
42.2
▼ 1.6 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 3 million
▼ 1% vs 2024
€ 70,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 298,965
▲ 164% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 6.9 million
▲ 46% vs 2024
€ 1.1 million is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.
€ 686,119
▲ 7% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 26 days on average.
€ 429,980
▼ 15% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 9,593,335 | € 10,528,254 | € 11,945,466 | € 12,437,117 | ▲ 4% |
| Profit after taxes | € 809,536 | € 502,921 | € 930,814 | € -169,264 | ▼ € 1.1 million |
| Equity | € 9,929,481 | € 10,432,402 | € 11,363,216 | € 13,193,952 | ▲ 16% |
| Total debts | € 13,828,512 | € 16,050,129 | € 17,961,016 | € 19,948,712 | ▲ 11% |
| Cash | € 655,808 | € 483,518 | € 692,064 | € 1,338,020 | ▲ 93% |
| Land & buildings | € 2,876,513 | € 2,709,331 | € 2,542,148 | € 2,374,891 | ▼ 7% |
| Retained profit | € 4,646,032 | € 5,148,953 | € 6,079,767 | € 5,910,503 | ▼ 3% |
| Bank debt | € 3,864,147 | € 4,162,086 | € 4,742,308 | € 6,905,773 | ▲ 46% |
| Balance sheet total | € 23,844,705 | € 26,560,502 | € 29,393,462 | € 33,203,153 | ▲ 13% |
| Employees (FTE) | 35.9 | 40.9 | 43.8 | 42.2 | ▼ 1.6 |
Key figures of PHARMACIE LEJEUNE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE LEJEUNE?
What happened at PHARMACIE LEJEUNE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Luc OLIVIER stepped down as director. NBB
- Liliane LEJEUNE stepped down as director. NBB
- François-Xavier OLIVIER stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 169,264 (▼ € 1.1 million vs 2024). Source: NBB ↗
- New establishment in Amay. KBO
- New establishment in Modave. KBO
- New establishment in Villers-le-Bouillet. KBO
- Luc OLIVIER became a director. NBB
In short
From € 809,536 profit in 2022 to € 169,264 loss in 2025.
Paid € 46,961 in corporate taxes since 2022.
Best year ever: 2024, with € 930,814 profit.
Pays suppliers within 26 days on average.
A new publication or filing at PHARMACIE LEJEUNE? We notify you, reason included.
Follow PHARMACIE LEJEUNEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
It owns 100% of TRIMEPHAR, 100% of PHARMACIE JASSOGNE, 100% of PHARMACIE DE DONCEEL, 100% of PHARMACIE GUSTIN, 100% of PHARMACIE KAIRIS and 100% of PHARMACIE DUBOIS-HUSSON itself.
Directors
According to the 2025 annual accounts
since 2023 · until 2029
since 2023 · until 2029
since 2023 · until 2029
Establishments
Establishment units
Physical locations of this company
Rue de la Champignotte(AIN) 13
4317 Faimes
Rue des Combattants 17
6997 Erezée
Active since 13 January 1988
Rue de la Station 6
5300 Andenne
Active since 1 January 1988
Route d'Erezée 9
6960 Manhay
Active since 1 January 1988
Boulevard des Gérardchamps 40
4800 Verviers
Active since 1 January 1988
Avenue de Criel(H) 14
5370 Havelange
Active since 1 July 2012
Avenue H. Dumont(AMP) 7
4540 Amay
Active since 1 July 2012
Grand'rue (ROWE) 43
4560 Clavier
Active since 1 January 2015
Rue Joseph Wauters(AMA) 2
4540 Amay
Active since 25 May 2020
Quai de l'Ourthe 20
4170 Comblain-au-Pont
Active since 25 May 2020
Route de Strée 50
4577 Modave
Active since 1 October 2023
Rue de l'Entreprise 12
4530 Villers-le-Bouillet
Active since 1 October 2023
Chaussée Roosevelt(AMA) 43
4540 Amay
Active since 1 September 2024
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 16 companies are registered at this address.
All companies at this address →Pharmacie J.P. Detry - Discry same network
€ 255,389 gross margin · 2025
PHARMACIE DE DONCEEL same network
€ 175,420 gross margin · 2025
PHARMACIE DUBOIS-HUSSON same network
€ 475,076 gross margin · 2025
Pharmacie DETRY-DUPONT same network
€ 297,327 gross margin · 2025
PHARMACIE R. WALNIER same network
€ 463,240 gross margin · 2025
+11 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0432.865.270
- VAT number
- BE 0432.865.270
- Registered office
- Rue de la Champignotte(AIN) 13, 4317 Faimes
- Names & denominations
- PHARMACIE LEJEUNE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 31 December 1987
- Peppol
- Active · Active since 10 Sept 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers